Breast cancer is the most common cancer among women, with over 2.3 million cases diagnosed globally each year. While current detection methods like mammograms and self-exams are valuable, they’re not without limitations. But what if a simple blood test could revolutionize early detection and save countless lives?
In this episode of Balancing the Future, Dana and Micah are joined by Ivana Domljanovic, a researcher at the forefront of breast cancer detection technology. Together, they explore how biomarkers in blood could transform cancer screening and monitoring — integrating seamlessly into routine blood work to make testing more accessible, efficient, and frequent.
Ivana also shares her vision for the future, including the exciting potential for at-home testing kits that empower individuals to monitor their health from the comfort of their homes.
Ivana’s journey into this groundbreaking field began during her PhD studies, sparked by a professor focusing on breast cancer research. At the time, her primary interest was in using nanostructures and DNA origami to detect dysregulation in microRNAs.
LINKS:
SOURCES:
Join hosts Dana Clémençon and Micah Schweizer on Balancing the Future from METTLER TOLEDO, where they delve into the world of sustainable technology and its transformative impact on our lives.
Each episode features stories from leading innovators, breaking down complex tech advancements into engaging narratives that reveal how these innovations shape our present and future.
From the origins of new technologies to their individual and societal implications, this podcast offers a compelling look at the future of sustainability.